Worldwide Life Science Analytics Industry to 2029 - Increasing Acceptance of Analytics Solutions in Clinical Trials is Driving Growth - ResearchAndMarkets.com

2022-11-23
DUBLIN--(BUSINESS WIRE)--The "Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region - Global Forecast to 2029'
The life science analytics market size is estimated to be USD 24.6 billion in 2021 and is expected to witness a CAGR of 15.31% during the forecast period 2022-2029.
Technological advancements, data storage in the life sciences industry, increasing acceptance of analytics solutions in clinical trials, rising adoption of analytics for sales and marketing applications, and demand for improved data standardisation are some of the major factors that boosts global market growth.
Also, rising incidence of chronic diseases, mounting pressure to reduce healthcare spending, and the need for improved patient outcomes are other factors that propelling the growth during the forecast period. However, high implementation cost hindering the market growth.
Companies Mentioned
Accenture (Ireland)
IQVIA (US)
Wipro (India)
Cognizant (US)
Allscripts Healthcare Solutions (US)
Infosys Limited (US)
MaxisIT (US)
Optum (US)
Cotiviti (US)
This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including component, type, application, delivery, and end user from 2021 to 2029.
Segmentation: Life Science Analytics Market Report 2021-2029
By Component (Revenue, USD Billion)
Software
Services
By Type (Revenue, USD Billion)
Descriptive
Reporting
Prescriptive
Predictive
By Application (Revenue, USD Billion)
Sales & Marketing Support
Supply Chain Analytics
Pharmacovigilance
Regulatory Compliance
By Delivery (Revenue, USD Billion)
On-premises
On-demand
By End User (Revenue, USD Billion)
Biotechnology
Pharmaceutical
Others
By Region (Revenue, USD Billion)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/85btx1
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。